I have there are no listed patents on the books or any licensing deals reported. If the company owned the patent rights they would pay for its yearly maintenance and list the patent and its expenses within its disclosures. They have not...so basically if it’s not in black and white it’s just fluffery.
“ They own the rights to the patent yes they do. Check back in the filings. “
Well that was wrong. Gpft does not own the IP by any stretch. The small pharma is the patent holder and is purportedly licensing out this tech to gpft for 100% of USA .All of this reported by gpft not Zylo therapeutics and no 8k accompanied any of it. If zylo has the nutflush for smokeless Thc delivery then they would be idiotic to get in bed with only one weak otc company years away from profitability... unless of course gpft forked over a giant chunk of change. I’ve seen the books and didn’t to see any 100M licensing fee.
The Q will be more of the same. Mounting losses and unsustainable cash combustion. COVID will come in handy and another excuse!
News 
Market Data 
Discover 
AI
